Hepatotoxicity of Green Tea Extract: Idiosyncratic or Indirect Drug-induced Liver Injury?

Keywords

Green tea extract / Epigallocatechin gallate / Drug-induced liver injury / Idiosyncratic hepatotoxicity / Indirect drug-induced liver injury

Acknowledgments

We thank the National Natural Science Foundation of China for helping in funding the sources.

Funding

The work was supported by a grant from the National Natural Science Foundation of China (No. 81630100).

Conflict of interest

XHX has been the Honorary Editor-in-Chief of Future Integrative Medicine since September 2021. The other authors declare that they have no conflict of interest related to this publication.

Author contributions

Study concept and design (XHX, ZFB, XZ, and DKX), acquisition of the literature and data (YJG and CZW), drafting of the manu-script (YJG, XZ, DKX, WS, and HJY), and critical revision of the manuscript for important intellectual content (XHX, ZFB, XZ, and YJG), All authors have made a significant contribution to this let-ter and have approved the final manuscript.

References

[1] Hoofnagle JH, Bonkovsky HL, Phillips EJ, Li YJ, Ahmad J, Barnhart H, et al. Drug-Induced Liver Injury Network. HLA-B*35:01 and Green Tea-Induced Liver Injury. Hepatology 2021; 73:2484-2493. doi:10.1002/hep.31538,PMID:32892374.

[2] Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR. Practice Parameters Committee of the American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol 2021; 116(5):878-898. doi:10.14309/ajg.0000000000001259,PMID:33929376.

[3] Zheng EX, Rossi S, Fontana RJ, Vuppalanchi R, Hoofnagle JH, Khan I, et al. Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK(®) Weight Loss Products: Results from the DILIN Prospec-tive Study. Drug Saf 2016; 39(8):749-754. doi:10.1007/s40264-016-0428-7,PMID:27189593.

[4] Shi Z, Zhu JX, Guo YM, Niu M, Zhang L, Tu C, et al. Epigallocatechin Gallate During Dietary Restriction - Potential Mechanisms of En-hanced Liver Injury. Front Pharmacol 2021;11:609378. doi:10.3389/fphar.2020.609378,PMID:33584288.

[5] Zarezadeh M, Saedisomeolia A, Shekarabi M, Khorshidi M, Emami MR, Müller DJ. The effect of obesity, macronutrients, fasting and nutritional status on drug-metabolizing cytochrome P450s: a sys-tematic review of current evidence on human studies. Eur J Nutr 2021; 60:2905-2921. doi:10.1007/s00394-020-02421-y,PMID:33141242.

[6] Kapetanovic IM, Crowell JA, Krishnaraj R, Zakharov A, Lindeblad M, Lyubimov A. Exposure and toxicity of green tea polyphenols in fast-ed and non-fasted dogs. Toxicology 2009; 260:28-36. doi:10.1016/j.tox.2009.03.007, PMID:19464566.

[7] Chow HH, Hakim IA, Vining DR, Crowell JA, Ranger-Moore J, Chew WM, et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 2005; 11:4627-4633. doi:10.1158/1078-0432.CCR-04-2549,PMID:15958649.

[8] Oketch-Rabah HA, Roe AL, Rider CV, Bonkovsky HL, Giancaspro GI, Nav-arro V, et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep 2020; 7:386-402. doi:10.1016/j.toxrep.2020.02.008,PMID:32140423.

[9] Li CY, Li XF, Tu C, Li N, Ma ZJ, Pang JY, et al. The idiosyncratic hepato-toxicity of Polygonum multiflorum based on endotoxin model. Yaoxue Xuebao 2015; 50(1):28-33. PMID:25924471.

[10] Zhu Y, Liu SH, Wang JB, Song HB, Li YG, He TT, et al. Clinical Analysis of Drug-induced Liver Injury Caused by Polygonum multiflorum and its Preparations. Zhongguo Zhongxiyi Jiehe Zazhi 2015; 35(12):1442-1447. PMID:26882605.

[11] Li CP, Rao T, Chen XP, Zou ZS, Wei AW, Tang JF, et al. HLA-B*35:01 Al-lele Is a Potential Biomarker for Predicting Polygonum multiflorum-Induced Liver Injury in Humans. Hepatology 2019; 70(1):346-357. doi:10.1002/hep.30660,PMID:30985007.

[12] Hoofnagle JH, Björnsson ES. Drug-Induced Liver Injury-Types and P-henotypes. N Engl J Med 2019; 381(3):264-273. doi:10.1056/NEJM-ra1816149,PMID:31314970.

[13] Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol 2015; 12(4):231-242. doi:10.1038/nrgastro.2015.35,PMID:25782093.

[14] Rocco A, Compare D, Angrisani D, Sanduzzi Zamparelli M, Nardone G. Alcoholic disease: liver and beyond. World J Gastroenterol 2014; 20(40):14652-9. doi:10.3748/wjg.v20.i40.14652,PMID:25356028.

[15] Cederbaum AI. Alcohol metabolism. Clin Liver Dis 2012; 16(4):667-685. doi:10.1016/j.cld.2012.08.002,PMID:23101976.

[16] James KD, Kennett MJ, Lambert JD. Potential role of the mitochondria as a target for the hepatotoxic effects of (-)-epigallocatechin-3-gal-late in mice. Food Chem Toxicol 2018; 111:302-309. doi:10.1016/j.fct.2017.11.029, PMID:29175576.